Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
08/19AB Science annouces the success of a private placement
GL
08/19SCIENCE : AB Science annouces the success of a private placement
GL
08/19FORTRESS BIOTECH, INC. (NASDAQ : FBIO) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
AQ
08/19RESHAPE LIFESCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
08/19RESOLVING TOWARDS RESILIENCE : Managing Stress to Increase Engagement
PU
08/19NASCENT BIOTECH : Has Entered into an Agreement to Perform Phase I Clinical Study for Brain Cancer
AQ
08/19PHSC : Director's Dealing
PU
08/19ABIVAX : First patient enrolled in Abivax ABX464-103 Phase 2b Clinical Trial in Patients with Ulcerative Colitis
PU
08/19INVICTUS MD STRATEGIES CORP : . Opens the Market
AQ
08/19AGILENT TECHNOLOGIES : OFS Academy Receives Learning!100 Award for Third Consecutive Year; Company recognized for its efforts to develop employee talents
AQ
08/19AGILENT TECHNOLOGIES : NUS, Agilent, and NUH launch new translational R&D hub to boost clinical diagnostics; S$38 million research facility aims to be a premier, global, one-stop hub for research and translation to clinical testing through biochemical innovation and techniques
AQ
08/19OSSUR HF : Transactions in relation to share buyback program
PU
08/19PHILIPS RECEIVES THE RED DOT DESIGN AWARD : ‘Best of the Best' as a brand
PU
08/19EARTH SCIENCE TECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-Q)
AQ
08/19ORTHOPEDIATRICS : Receives FDA Clearance for Pediatric-Specific Foot System
AQ
Discover
08/19DATA ON ORGANIC RESEARCH REPORTED BY RESEARCHERS AT BRISTOL-MYERS SQUIBB COMPANY (SYNERGISTIC SOLVATION EFFECTS : Enhanced Compound Solubility Using Binary Solvent Mixtures): Life Science Research - Organic Research
AQ
08/19PATENT ISSUED FOR TOOTH MOVEMENT MEASUREMENT BY AUTOMATIC IMPRESSION MATCHING (USPTO 10,368,960) : Align Technology Inc.
AQ
08/19PIERRE : Management's Discussion and Analysis of Financial Conditions and Results of Operations
AQ
08/19“TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS” IN PATENT APPLICATION APPROVAL PROCESS (USPTO 20190233435) : Incyte Corporation
AQ
08/19AERIE PHARMACEUTICALS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS, UPDATES FULL-YEAR 2019 GUIDANCE AND PROVIDES BUSINESS UPDATE : Aerie Pharmaceuticals Inc.
AQ
08/19PATENT ISSUED FOR IMAGING APPARATUS (USPTO 10,375,298) : Olympus Corporation
AQ
08/19PATENT ISSUED FOR PROSTHETIC FOOT WITH ENHANCED STABILITY AND ELASTIC ENERGY RETURN (USPTO 10,369,019) : Ossur HF
AQ
08/19TENET REPORTS RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2019 : Tenet Healthcare Corporation
AQ
08/19PATENT ISSUED FOR CELL CULTURE PACKAGE AND PACKAGE CONTAINING CELL-CULTURE MATERIAL (USPTO 10,370,631) : Japan Tissue Engineering Co Ltd.
AQ
08/19RESEARCHERS SUBMIT PATENT APPLICATION, “CONTINUOUS FLOW SEPARATION CHAMBER”, FOR APPROVAL (USPTO 20190231965) : Haemonetics Corporation
AQ
08/19FIVE STAR SENIOR LIVING INC. ANNOUNCES ITS SECOND QUARTER 2019 RESULTS : Five Star Senior Living Inc.
AQ
08/19RESEARCHERS SUBMIT PATENT APPLICATION, “METHODS FOR TREATING OCULAR DISEASE USING INHIBITORS OF CSF-1R”, FOR APPROVAL (USPTO 20190231765) : Novartis AG
AQ
08/19MEITHEAL PHARMACEUTICALS ANNOUNCES INVESTMENT FROM NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL COMPANY FOR MAJORITY STAKE : Meitheal Pharmaceuticals
AQ
08/19RESEARCHERS SUBMIT PATENT APPLICATION, “PROCESSES AND INTERMEDIATES FOR MAKING A JAK INHIBITOR”, FOR APPROVAL (USPTO 20190233392) : Incyte Corporation
AQ
08/19PERKINELMER LAUNCHES EUROIMMUN ELISA FOR DETECTION OF ASPERGILLUS INFECTIONS : PerkinElmer Inc.
AQ
08/19NUO THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/19PATENT ISSUED FOR TORQUE REACTION IN ROTATING MEDICAL APPARATUS (USPTO 10,371,232) : Elekta Limited
AQ
08/19PDL BIOPHARMA, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
08/19iBio Inks 3D Bioprinting Agreement
GL
08/19ARROWHEAD PHARMACEUTICALS DOSES FIRST PATIENT IN SEQUOIA PHASE 2/3 STUDY OF ARO-AAT FOR TREATMENT OF ALPHA-1 LIVER DISEASE : Arrowhead Pharmaceuticals Inc.
AQ
08/19PATENT APPLICATION TITLED “BIOMATERIAL DISPENSING DEVICE” PUBLISHED ONLINE (USPTO 20190231407) : Globus Medical Inc.
AQ
08/19IMAC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
08/19ACERUS ANNOUNCES TEMPORARY UNAVAILABILITY OF NATESTO® IN CANADA AND SOUTH KOREA : Acerus Pharmaceuticals Corporation
AQ
08/19Atrion Corporation Increases Quarterly Cash Dividend by 15%
GL
08/19The Ensign Group Announces Appointment of Chief Financial Officer of The Pennant Group
GL
08/19RESEARCHERS FROM BEIJING ADVANCED INNOVATION CENTER FOR FOOD NUTRITION AND HUMAN HEALTH REPORT FINDINGS IN BIOLOGICAL MACROMOLECULES (THE INCREASED STICKINESS OF NON-GLUTINOUS RICE BY ALKALI SOAKING AND ITS MOLECULAR CAUSES) : Life Science Research - Biological Macromolecules
AQ
08/19JAPAN - PATENT ISSUED FOR ENDOSCOPE (USPTO 10,368,721) : Olympus Corporation
AQ
08/19PRECEDEX INTRAVENOUS SOLUTION SPECIAL INVESTIGATION (IN PEDIATRIC PATIENTS) : Drugs and Therapies - Anxiolytics Sedatives and Hypnotics
AQ
08/19REGENICIN : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/19MERIT MEDICAL : Report of unscheduled material events or corporate event
PU
08/19ZYMEWORKS REPORTS 2019 SECOND QUARTER FINANCIAL RESULTS : Zymeworks Inc.
AQ
08/19TRICIDA, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
08/19MERIT MEDICAL SYSTEMS INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
08/19BOSTON SCIENTIFIC : Description Statement of Changes in Beneficial Ownership
PU
08/19ELI LILLY AND : Lilly Announces Webcast to Discuss World Conference on Lung Cancer Presentation
PR
08/19TENET HEALTHCARE : Appoints Nadja West, M.D., as New Independent Director
BU
08/19JOHNSON & JOHNSON : Congo to use second vaccine to fight Ebola
AQ
08/19NUTRALIFE BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/19VEEVA SYSTEMS INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
08/19MANHATTAN SCIENTIFICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
08/19SANOFI : Once shelved as too risky, blood cancer drug discovered in San Diego gets FDA approval
AQ
08/19NETWORKNEWSBREAKS – PREDICTIVE ONCOLOGY INC. (NASDAQ : POAI) to Report Q2 2019 Results, Host Conference Call after Market Close
AQ
08/19HEDGEPATH PHARMACEUTICALS : Announces Name Change to INHIBITOR Therapeutics, Inc. and Ticker Symbol Change to "INTI" Effective August 20, 2019
PR
08/19VEEVA : Mary Lynne Hedley Joins Veeva Board of Directors
BU
08/19MODERNA : Receives FDA Fast Track Designation for Zika Vaccine mRNA-1893
BU
08/19DECIPHERA PHARMACEUTICALS : Announces Closing of Public Offering of Common Stock
BU
08/19Merus Announces Financial Results for the Second Quarter 2019 and Provides Business Update
GL
08/19Rosen Law Firm Announces Investigation of Securities Claims Against Novartis AG – NVS
BU
08/19Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta™ (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)
GL
08/19ADVANZEON : Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces Strategic Relationship with Crank Communications
AQ
Discover
08/19Predictive Oncology Inc. Reports Second Quarter 2019 Financial Results and Provides Corporate Update
GL
08/19AMERICAN CRYOSTEM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATIONS (form 10-Q)
AQ
08/19PATENT ISSUED FOR ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER (USPTO 10,369,132) : Mei Pharma Inc.
AQ
08/19AN APPLICATION FOR THE TRADEMARK “TECARTZA” HAS BEEN FILED BY GILEAD SCIENCES : Gilead Sciences
AQ
08/19R1 RCM to Present at the Baird 2019 Global Healthcare Conference
GL
Prev.1  2  3   4  5  6  7  8  9  10Next
Advertisement